QBI · School of Pharmacy

How one private biotech seized on JPM to emerge from stealth and tell its story

Wed Jan 25, 2023

UCSF School of Pharmacy leads in NIH funding for the 42nd straight year

Tue Feb 15, 2022

Susan Merrell

Nadav Ahituv, PhD (right), works in his lab with postdoctoral researcher Fumitaka Inoue, PhD.

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school for the 42nd consecutive year.

Map of protein systems reveals new targets for cancer treatment

Thu Dec 9, 2021

Krogan Lab

A birds-eye depiction of the findings from the Quantitative Biosciences Institute’s recent work on cancer. Each node represents a protein system and darker-colored nodes are more likely to be involved in cancer.

Scientists at the UCSF Quantitative Biosciences institute developed a new approach for understanding cancer and applied it to breast cancer and cancers of the neck and head

How cells multitask: the magic of molecular switches

Thu Oct 21, 2021

Elisabeth Fall

Tanja Kortemme, PhD

Research unearths new details about the protein networks that keep cells healthy

Cancer drug stops SARS-CoV-2 in the lab

Thu Feb 11, 2021

PharmaMar

Aplidin is extracted from Aplidium albicans, a sea squirt found off the coast of Spain.

“If you get a drug that targets a human protein, it would be incredibly hard for the virus to mutate away from being reliant on it,” said Nevan Krogan, the director of QBI.

A genetic shortcut to help visualize proteins at work

Fri Dec 11, 2020

QBI probes three lethal coronaviruses to find possible drug targets

Fri Oct 23, 2020

Blue dots show MERS-CoV particles on the surface of a cell

National Institute of Allergy and Infectious Diseases (NIAID)

Middle East respiratory syndrome coronavirus (MERS-CoV) viral particles under an electron microscopic.

“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.